Vereinbarkeit des EU-Vorschlags für eine Verordnung über mit bestimmten neuen genomischen Techniken (NGT) gewonnenen Pflanzen mit dem Cartagena Protokoll über die biologische Sicherheit
Within the European Union (EU), negotiations are currently underway on a new regulation concerning plants obtained through new genomic techniques (NGT plants). In the future, these plants are to be regulated differently from genetically modified organisms (GMOs) and partially deregulated. Since both the EU and its Member States are parties to the Cartagena Protocol on Biosafety, any new EU regulation must comply with the provisions of this international treaty.
A central question addressed by the authors is therefore whether NGT plants fall within the scope of the Cartagena Protocol, which establishes procedural requirements for so-called living modified organisms (LMOs).
The analysis further examines whether the proposed EU regulation is consistent with the Cartagena Protocol’s requirements regarding risk assessments, notification and information obligations, as well as labelling and identification duties.
The authors argue that these requirements are only partially fulfilled. To ensure consistency with the Cartagena Protocol, any future regulation — departing from the current proposal — should, first, maintain all notification and identification obligations for NGT plants vis-à-vis non-EU States; and second, guarantee the traceability of NGT-1 plants within the EU. Without such traceability, compliance with notification and identification duties towards third countries could not be ensured.
Autor(en)
Prof. Dr. Silja Vöneky, Constantin Born, Laura Tribess, Dr. Silke Weller
Contentpartner
© Lexxion Verlagsgesellschaft mbH
Publikation
EurUP 04 / 2025 (November 2025)
Verkaufspreis
€ 32,00